187 related articles for article (PubMed ID: 7229915)
1. Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.
Jansen JA
J Pharmacokinet Biopharm; 1981 Feb; 9(1):15-26. PubMed ID: 7229915
[TBL] [Abstract][Full Text] [Related]
2. Hepatic elimination of drugs with concentration-dependent serum protein binding.
Huang JD; Oie S
J Pharmacokinet Biopharm; 1984 Feb; 12(1):67-81. PubMed ID: 6747819
[TBL] [Abstract][Full Text] [Related]
3. Determination of hepatic clearance with the account of drug-protein binding kinetics.
Berezhkovskiy LM
J Pharm Sci; 2012 Oct; 101(10):3936-45. PubMed ID: 22767378
[TBL] [Abstract][Full Text] [Related]
4. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
Deshmukh SV; Harsch A
J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
[TBL] [Abstract][Full Text] [Related]
5. Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.
Yan Z; Ma L; Carione P; Huang J; Hwang N; Kenny JR; Hop CECA
J Pharm Sci; 2024 Apr; 113(4):1094-1112. PubMed ID: 38220087
[TBL] [Abstract][Full Text] [Related]
6. Commentary: a physiological approach to hepatic drug clearance.
Wilkinson GR; Shand DG
Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
[TBL] [Abstract][Full Text] [Related]
7. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation.
Wang HJ; Benet LZ
Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869
[TBL] [Abstract][Full Text] [Related]
8. Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.
Meijer DK; van der Sluijs P
Pharm Res; 1989 Feb; 6(2):105-18. PubMed ID: 2668913
[TBL] [Abstract][Full Text] [Related]
9. Variation in hepatic extraction ratio with unbound drug fraction: discrimination between models of hepatic drug elimination.
Byrne AJ; Morgan DJ; Harrison PM; McLean AJ
J Pharm Sci; 1985 Feb; 74(2):205-7. PubMed ID: 3989694
[TBL] [Abstract][Full Text] [Related]
10. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A
Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632
[TBL] [Abstract][Full Text] [Related]
11. A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.
Roberts MS; Rowland M
J Pharmacokinet Biopharm; 1986 Jun; 14(3):261-88. PubMed ID: 3783447
[TBL] [Abstract][Full Text] [Related]
12. On the influence of protein binding on pharmacological activity of drugs.
Berezhkovskiy LM
J Pharm Sci; 2010 Apr; 99(4):2153-65. PubMed ID: 19827100
[TBL] [Abstract][Full Text] [Related]
13. Effect of plasma protein binding on quinidine kinetics in the rabbit.
Guentert TW; Oie S
J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
[TBL] [Abstract][Full Text] [Related]
14. Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality?
Pang KS; Han YR; Noh K; Lee PI; Rowland M
Biochem Pharmacol; 2019 Nov; 169():113596. PubMed ID: 31398312
[TBL] [Abstract][Full Text] [Related]
15. Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.
Pang KS; Rowland M
J Pharmacokinet Biopharm; 1977 Dec; 5(6):625-53. PubMed ID: 599411
[No Abstract] [Full Text] [Related]
16. Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction.
Smallwood RH; Mihaly GW; Smallwood RA; Morgan DJ
J Pharmacokinet Biopharm; 1988 Oct; 16(5):529-42. PubMed ID: 3199317
[TBL] [Abstract][Full Text] [Related]
17. Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.
Wagner JG
Eur J Clin Pharmacol; 1976; 10(6):425-32. PubMed ID: 1001358
[TBL] [Abstract][Full Text] [Related]
18. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
Berezhkovskiy LM
J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
Yuan R; Venitz J
Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
[TBL] [Abstract][Full Text] [Related]
20. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
